Multi-parameter ultrasound based on the logistic regression model in the differential diagnosis of hepatocellular adenoma and focal nodular hyperplasia

Table 1 Comparison of clinical data between hepatocellular adenoma group and focal nodular hyperplasia group

	HCA group, n = 31	FNH group, n = 50	t/χ2 value	P value
Age	27.29 ± 9.87	28.09 ± 10.57	0.339	0.735
Gender, male/female	8/23	24/26	3.994	0.047
History of viral infection	6%	9%	0.023	0.879
History of cirrhosis	4%	6%	0.014	0.904
ALT, U/L	24.83 ± 12.94	28.76 ± 15.38	1.185	0.239
AST, U/L	29.83 ± 12.85	26.92 ± 13.64	0.954	0.343
GGT, U/L	38.32 ± 14.08	30.84 ± 10.36	1.529	0.183
Albumin, g/L	48.23 ± 3.82	47.93 ± 3.58	0.482	0.528
Tbil, μmol/L	9.38 ± 4.83	10.63 ± 5.63	0.392	0.682
PT, s	12.86 ± 0.86	12.67 ± 0.74	1.055	0.295
AFP, μg/L	14.05 ± 5.97	12.39 ± 4.29	1.454	0.150
SF, μg/L	89.35 ± 35.24	96.32 ± 43.2	0.755	0.452

HCA: Hepatocellular adenoma; FNH: Focal nodular hyperplasia; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Glutamyl transpeptidase; Tbil: Total bilirubin; PT: Prothrombin time; AFP: Alpha-fetoprotein; SF: Serum ferritin.